Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in research settings for constructing pyridine-based bioactive molecules. Also utilized in agrochemical research for designing novel pesticides with improved environmental profiles. The compound's trifluoromethyl and bromo functional groups allow for further chemical modifications through cross-coupling reactions, making it valuable in medicinal chemistry and drug discovery pipelines.